BioVersys AG (SWX:BIOV)
Switzerland
· Delayed Price · Currency is CHF 23.00
-1.90 (-7.63%)
At close: Mar 9, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 149.71 million as of March 9, 2026. Its market cap has decreased by -25.71% in one year.
Market Cap
149.71M
Enterprise Value
75.89M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.00
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 149.71M, a decrease of -28.00%. That is a compound annual growth rate of -26.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 149.71M | 4.92% |
| Dec 30, 2025 | 142.69M | -31.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 145.86M |
| Xlife Sciences AG | 127.46M |
| Santhera Pharmaceuticals Holding AG | 213.08M |
| Newron Pharmaceuticals | 366.19M |
| Basilea Pharmaceutica AG | 649.00M |
| Idorsia | 910.45M |
| EvoNext Holdings | 6.27M |
| Addex Therapeutics | 5.25M |